Making the discoveries that defeat cancer

  • Home |
  • About Us  |
  • Research  |
  • Enterprise  |
  • Education  |
  • Jobs  |
  • Support Us  |
  • News  |
  • Contact Us
  • Home »
  • Research »
  • Research Highlights »
  • Research Highlight Archive

Research

  • ICR Ranking on RAE
  • Research Highlights
  • Publications Repository
  • Research Divisions
  • Team Leaders
  • Biomedical Research Centre
  • REF 2014

Fewer Treatments For Infants With Cancer

05 Mar 2009 - Some infants diagnosed with a particular form of childhood cancer do not require intensive treatment and in some cases need no treatment at all in order to survive their cancer, known as “non MYCN amplified neuroblastoma”

Professor Andy Pearson at The Institute of Cancer Research (ICR) has led two European trials.

“By limiting treatment we are significantly reducing the risks and side-effects for these very young patients while maintaining their likelihood of survival. In some cases, chemotherapy can cause children to feel tired, sick and the treatment makes it more likely they’ll pick up infections, so it’s important to avoid this where possible. Our current goal is to individualise or personalise treatment for children with neuroblastoma.”

In its aggressive form, neuroblastoma is a major cause of death from cancer for children.

Back to other research highlights

Related Links


Last updated: 17 February 2010

  • Contacts  | 
  • Privacy  | 
  • Terms and Conditions  | 
  • Accessibility  | 
  • Feedback  | 
  • Cookies  | 
  • Status
  • ICR News RSS Feed
  • Find us on Facebook
  • Follow us on Twitter